Hilmi Ataseven

1.0k total citations
50 papers, 680 citations indexed

About

Hilmi Ataseven is a scholar working on Surgery, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Hilmi Ataseven has authored 50 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 10 papers in Computational Theory and Mathematics and 9 papers in Molecular Biology. Recurrent topics in Hilmi Ataseven's work include Computational Drug Discovery Methods (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Hilmi Ataseven is often cited by papers focused on Computational Drug Discovery Methods (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Hilmi Ataseven collaborates with scholars based in Türkiye, Somalia and Azerbaijan. Hilmi Ataseven's co-authors include Ramazan Gen, Koray Sayın, Burak Tüzün, Mehmet Emin Demir, İlhami Yüksel, Ömer Başar, İbrahim Ertuğrul, Nurgül Şaşmaz, Mehmet İbi̇ş and Şafak Şahin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Gastroenterology & Hepatology and Gastrointestinal Endoscopy.

In The Last Decade

Hilmi Ataseven

43 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilmi Ataseven Türkiye 16 222 146 130 105 83 50 680
Kohshi Nishiguchi Japan 19 215 1.0× 318 2.2× 86 0.7× 44 0.4× 27 0.3× 81 1.2k
Marina H. de Jager Netherlands 17 168 0.8× 277 1.9× 120 0.9× 218 2.1× 39 0.5× 26 1.2k
So Young Yoon South Korea 18 78 0.4× 163 1.1× 108 0.8× 48 0.5× 52 0.6× 59 821
Timothy M. Chapman United Kingdom 19 87 0.4× 304 2.1× 76 0.6× 386 3.7× 39 0.5× 23 1.0k
Jung Min Yoon South Korea 11 83 0.4× 189 1.3× 117 0.9× 74 0.7× 19 0.2× 33 529
Susan K. Paulson United States 17 370 1.7× 170 1.2× 497 3.8× 91 0.9× 125 1.5× 31 1.7k
Hiroshi Maruyama Japan 20 479 2.2× 339 2.3× 101 0.8× 109 1.0× 76 0.9× 136 1.5k
J. J. Keating Ireland 16 149 0.7× 100 0.7× 202 1.6× 49 0.5× 20 0.2× 35 701
Delyth Clemett United Kingdom 11 102 0.5× 200 1.4× 117 0.9× 140 1.3× 18 0.2× 13 1.0k
Ahmad Y. Abuhelwa Australia 17 112 0.5× 240 1.6× 116 0.9× 20 0.2× 36 0.4× 65 1.1k

Countries citing papers authored by Hilmi Ataseven

Since Specialization
Citations

This map shows the geographic impact of Hilmi Ataseven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilmi Ataseven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilmi Ataseven more than expected).

Fields of papers citing papers by Hilmi Ataseven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilmi Ataseven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilmi Ataseven. The network helps show where Hilmi Ataseven may publish in the future.

Co-authorship network of co-authors of Hilmi Ataseven

This figure shows the co-authorship network connecting the top 25 collaborators of Hilmi Ataseven. A scholar is included among the top collaborators of Hilmi Ataseven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilmi Ataseven. Hilmi Ataseven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sayın, Koray & Hilmi Ataseven. (2023). Structural, Electronic, ADME and p450 Analyses of Boron Containing Compounds against Omicron Variant (B.1.1.529) in SARS-CoV-2. SHILAP Revista de lepidopterología. 44(1). 72–80. 3 indexed citations
3.
Ataseven, Hilmi, et al.. (2023). Mechanism of anticancer effect of gambogic acid on gastric signet ring cell carcinoma. Medical Oncology. 40(9). 269–269. 10 indexed citations
4.
Ataseven, Hilmi, et al.. (2022). Investigation of Antiparasitic Properties of Benzimidazole Derivatives Against Amebiasis. DergiPark (Istanbul University). 6(2). 11–17.
5.
Özkaraca, Mustafa, et al.. (2022). Galium aparine L. protects against acetaminophen-induced hepatotoxicity in rats. Chemico-Biological Interactions. 366. 110119–110119. 5 indexed citations
6.
Tüzün, Burak, et al.. (2021). Could Peganum harmala be effective in the treatment of COVID-19?. Bratislavské lekárske listy/Bratislava medical journal. 122(9). 670–679. 14 indexed citations
7.
Tüzün, Burak, et al.. (2021). Are clarithromycin, azithromycin and their analogues effective in the treatment of COVID19?. Bratislavské lekárske listy/Bratislava medical journal. 122(2). 101–110. 25 indexed citations
8.
Ataseven, Hilmi, et al.. (2021). PANKREAS KANSERİ. 54(1). 59–65. 1 indexed citations
9.
Ergül, Mustafa, Koray Sayın, & Hilmi Ataseven. (2021). 2-Phenylethyne-1-Sulfonamide Derivatives as New Drugs Candidates for Heat Shock Protein 70 and Doublecortin-like Kinase. 5(1). 1–12. 2 indexed citations
10.
Ataseven, Hilmi, et al.. (2020). Salgın Dönemi Sağlık Hizmetlerinde Özgecilik (Diğerkâmlık). 5(2). 101–108.
11.
Ataseven, Hilmi, et al.. (2020). Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?. Medical Hypotheses. 143. 110018–110018. 14 indexed citations
12.
Ergül, Mustafa, et al.. (2020). The Effects of Diurnal Intermittent Fasting On Proinflammatory Cytokine, Oxidative Stress and Heat Shock Protein 70 Levels. International Journal of Scientific and Technological Research. 3 indexed citations
13.
Tüzün, Burak, et al.. (2020). New anti-viral drugs for the treatment of COVID-19 instead of favipiravir. Journal of Biomolecular Structure and Dynamics. 39(18). 7263–7273. 54 indexed citations
14.
Ataseven, Hilmi, et al.. (2018). Primer Sklerozan Kolanjit. 11(2). 29–36. 1 indexed citations
15.
Kaya, Tijen, Ahmet Altun, Nergiz Hacer Turgut, Hilmi Ataseven, & Gökhan Köylüoğlu. (2016). Effects of a Multikinase Inhibitor Motesanib (AMG 706) Alone and Combined with the Selective DuP-697 COX-2 Inhibitor on Colorectal Cancer Cells. Asian Pacific Journal of Cancer Prevention. 17(3). 1103–1110. 11 indexed citations
16.
Ataseven, Hilmi, et al.. (2011). Prevalence and risk factors of gallbladder polyps in Erzurum region. DergiPark (Istanbul University). 1 indexed citations
17.
Ataseven, Hilmi, et al.. (2011). Prevalence and risk factors of gallbladder polyps in Erzurum region. Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi. 33(1). 48–52. 1 indexed citations
18.
Ataseven, Hilmi, et al.. (2010). Fatal rhinocerebral mucormycosis under the shade of hepatic encephalopathy. Annals of Hepatology. 9(4). 462–464. 2 indexed citations
19.
Ataseven, Hilmi, Erkan Parlak, İlhami Yüksel, et al.. (2009). Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis.. PubMed. 8(3). 312–5. 11 indexed citations
20.
Yüksel, İlhami, Ömer Başar, Hilmi Ataseven, et al.. (2008). Mucocutaneous manifestations in inflammatory bowel disease. Inflammatory Bowel Diseases. 15(4). 546–550. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026